Sign in
4

Changes in Ownership

CytomX Therapeutics, Inc. Filed Acc 0000899243-16-021477

Director sold 22,463 shares at $10.75 ($241,477)

From the SEC's structured data for this filing

Trades in this filing

Canaan IX L.P. · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2016-06-01 Sale : show line 1 in the form −22,463 $10.75 $241,477 4,463,927 I
Open-market sales · 22,463 sh · avg $10.75 · $241,477
Loading xslF345X03/doc4.xml…